Cover Image

Trifluridine/tipiracil as a therapeutic option in real life setting of metastatic colorectal cancer: An efficacy and safety analysis

Background: In the phase III RECOURSE trial, the orally administered combination trifluridine/tipiracil (FTD/TPI) demonstrated a survival benefit and an acceptable safety profile, earning approval as a third-line therapy in metastatic colorectal cancer (mCRC). This study aimed to assess the efficacy...

Full description

Saved in:

Bibliographic Details
Main Authors:	Daniel Sur (Author), Cristina Lungulescu (Author), Ștefan Spînu (Author), Alecsandra Gorzo (Author), Elena-Adriana Dumitrescu (Author), Dan Ionut Gheonea (Author), Cristian-Virgil Lungulescu (Author)
Format:	Book
Published:	Frontiers Media S.A., 2022-10-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Cost-effectiveness analysis of trifluridine/tipiracil combined with bevacizumab vs. monotherapy for third-line treatment of colorectal cancer
by: Long-Zhuan Huang, et al.
Published: (2024)

Signal mining and analysis of trifluridine/tipiracil adverse events based on real-world data from the FAERS database
by: Yongli Hu, et al.
Published: (2024)

Complete response to third-line treatment with trifluridine/tipiracil (TAS-102) in stage IV colon adenocarcinoma
by: Celia Lara-Morga, et al.
Published: (2023)

New bioanalytical microemulsion Electrokinetic chromatography method for the simultaneous determination of Trifluridine with its metabolites and Tipiracil in rat plasma: Application to pharmacokinetic studies
by: Mohamed Hefnawy, et al.
Published: (2019)

Pharmacokinetics, Safety, and Preliminary Efficacy of Oral Trifluridine/Tipiracil in Chinese Patients with Solid Tumors: A Phase 1b, Open-Label Study
by: Wang X, et al.
Published: (2020)

Digging in real-word electronic database for assessing CDK 4/6 inhibitors adherence in breast cancer patients from Romania
by: Adina Turcu-Stiolica, et al.
Published: (2024)

Up-and-Coming Experimental Drug Options for Metastatic Colorectal Cancer
by: Cimino SK, et al.
Published: (2020)

Targeting metastatic colorectal cancer – present and emerging treatment options
by: Ciombor KK, et al.
Published: (2014)

Occupational Carpal Tunnel Syndrome: a scoping review of causes, mechanisms, diagnosis, and intervention strategies
by: Alexandra-Daniela, et al.
Published: (2024)

Real-world comparison between weekly versus biweekly dosing of cetuximab for metastatic colorectal cancer
by: Himani Aggarwal, et al.
Published: (2023)

Association Between Regorafenib Dose and Efficacy Against Metastatic Colorectal Cancer in a Real-World Setting
by: Masahiro Hatori, et al.
Published: (2021)

Advances and Novel Treatment Options in Metastatic Melanoma
Published: (2022)

Immunotherapy regimens for metastatic colorectal carcinomas
by: Babar Bashir, et al.
Published: (2018)

Third-line treatment patterns and clinical outcomes for metastatic colorectal cancer: a retrospective real-world study
by: Ting Deng, et al.
Published: (2023)

Challenges in new vaccine introduction in a national program in India
by: Dipika Sur
Published: (2016)

Strengthening partnership towards excellence in public health
by: Dipika Sur
Published: (2013)

Current management options in metastatic renal cell cancer
by: Sittu Govindasamy Dinakaran Gangadaran
Published: (2017)

Targeted therapeutic options in early and metastatic NSCLC-overview
by: Gabriella Gálffy, et al.
Published: (2024)

Molecularly targeted drugs for metastatic colorectal cancer
by: Cheng YD, et al.
Published: (2013)

Colorectal cancer genomic biomarkers in the clinical management of patients with metastatic colorectal carcinoma
by: Anna Maria Rachiglio, et al.
Published: (2020)

Neurofibromatosis in Children: Actually and Perspectives
by: Maria Lucia Sur, et al.
Published: (2022)

Accurate detection of KRAS, NRAS and BRAF mutations in metastatic colorectal cancers by bridged nucleic acid-clamp real-time PCR
by: Yuki Nagakubo, et al.
Published: (2019)

A Holographic-Type Model in the Description of Polymer-Drug Delivery Processes
by: Irina Nica, et al.
Published: (2024)

IRINOTECAN, FLUOROURACIL AND LEUCOVORIN IN PATIENTS WITH METASTATIC COLORECTAL CANCER
by: Deyan Davidov
Published: (2008)

Metastatic Colorectal Cancer Resembling Severe Preeclampsia in Pregnancy
by: Raminder Kaur Khangura, et al.
Published: (2015)

Pharmacoeconomic evaluation of the effectiveness of therapy for metastatic colorectal cancer
by: Yu. Yu. Petukhova, et al.
Published: (2021)

Meeting An Unmet Need in Metastatic Colorectal Carcinoma with Regorafenib
by: Barbara Melosky
Published: (2016)

Advanced Therapeutic Options for Treatment of Metastatic Castration Resistant Prostatic Adenocarcinoma
by: Faiza Naseer, et al.
Published: (2021)

Türkçe Öğretmenlerinin Sınıfta Uyguladıkları Konuşma ve Yazma Etkinliklerine Yönelik Görüşlerinin Değerlendirilmesi
by: Gürbüz Çalışkan, et al.
Published: (2022)

Çevrim İçi Okuma Motivasyonu Ölçeği: Uyarlama, Geçerlik ve Güvenirlik Çalışması
by: Handan Çelik, et al.
Published: (2023)

Radiation dose and protection in dentistry
by: Tomohiro Okano, et al.
Published: (2010)

Evaluation of Nursing Profession within The Scope of professionalazation in Turkey and The Process of Harmonization to The European Union: A Qualitative Study
by: Bilgen Özlük, et al.
Published: (2017)

Chromatin factors: Ready to roll as biomarkers in metastatic colorectal cancer?
by: Cristina Moreta-Moraleda, et al.
Published: (2023)

TAS-102 in metastatic colorectal cancer (mCRC): efficacy, tolerability, and quality of life in heavily pretreated elderly patients: a real-life study
by: Giuseppe Cicero, et al.
Published: (2020)

Cetuximab Can Be an Effective and Low-Toxicity Maintenance Treatment Drug in Patients With Metastatic Colorectal Cancer: A Real-World Study of Zhejiang Cancer Hospital
by: Meiqin Yuan, et al.
Published: (2021)

NEW STRATEGIES IN LIVER SURGERY FOR IV STAGE METASTATIC COLORECTAL CANCER.
by: Nikola Y. Kolev, et al.
Published: (2012)

OXALIPLATIN/5-FLUOROURACIL/LEUCOVORIN IN THE TREATMENT OF PATIENTS WITH METASTATIC COLORECTAL CANCER
by: Deyan N. Davidov
Published: (2013)

CAPECITABINE AND IRINOTECAN AS FIRST- LINE CHEMOTHERAPY FOR PATIENTS WITH METASTATIC COLORECTAL CANCER
by: Deyan Davidov
Published: (2010)

Molecular targeted therapy for metastatic colorectal cancer: current and evolving approaches
by: Furong Li, et al.
Published: (2023)

Temporal and spatial heterogeneity of HER2 status in metastatic colorectal cancer
by: Flavia D'Angelo, et al.
Published: (2024)